Financhill
Back

UiPath Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
36

PATH
UiPath

Last Price:
12.24
Seasonality Move:
-23.6%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
44.46
Seasonality Move:
-13.89%
Sell
36
UiPath (PATH) is a Sell

Is UiPath a Buy, Sell or Hold?

  • The current UiPath [PATH] share price is $12.24. The Score for PATH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $44.46. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath's stock price today?

  • The UiPath share price today is $12.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PATH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $44.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 41.54 Sell
Chaikin Money Flow: 6412102 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.75 - 12.81) Sell
Bollinger Bands (100): (13.36 - 22.44) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: 680264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.4 - 43.64) Buy
Bollinger Bands (100): (40.21 - 47.85) Buy

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.39 Sell
20-day SMA: 12.48 Sell
50-day SMA: 14.26 Sell
200-day SMA: 19.51 Sell
8-day EMA: 12.33 Sell
20-day EMA: 12.54 Sell
50-day EMA: 14.19 Sell
200-day EMA: 17.91 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.06 Buy
20-day SMA: 42.2 Buy
50-day SMA: 41.3 Buy
200-day SMA: 42.91 Buy
8-day EMA: 43.52 Buy
20-day EMA: 42.63 Buy
50-day EMA: 42.31 Buy
200-day EMA: 43.24 Buy

UiPath Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.41 per share, and a decrease next year of $0.10 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

UiPath Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):